EGFR Exon 19 Deletion Mutation
4 clinical trials · Condition
◉ Watch EGFR Exon 19 Deletion Mutation
| Record | Firm | Date |
|---|---|---|
| Erlotinib Hydrochloride With or Without Bevacizumab in Treating Patients With Stage IV Non-small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutations (NCT01532089) | Academic and Community Cancer Research United | 2012-03-16 |
Track EGFR Exon 19 Deletion Mutation automatically
Every clearance here is in the API, with alerts when new ones post.